Prof. Dr. med. Adriano Aguzzi provides insight on the past, present, and future of prion and antibody therapy research in Switzerland. The Institute of Neuropathology works closely with the University Hospital of Zurich to conduct their research. He also touches on translating research to industry and his spinoff ImmunoQure, which screens patients for protective antibodies.
You have been leading the Institute of Neuropathology for nearly two decades now. How would you characterize the Institute’s mission today?
The Institute of Neuropathology’s mission is to better understand the basic mechanisms and causes of neurological diseases.
